Of interest, the two SMZL cases with mutations of CD79B and MYD88, respectively, showed increased numbers of immunoblasts spread among the smaller and typical marginal zone lymphoma cells (Figure 3). This evidence concerns the gene MYD88 and splenic marginal zone lymphoma.